Use of intravenous proton pump inhibitors in community practice: an explanation for the shortage?

The American Journal of Gastroenterology
Nalini M GudaNimish Vakil

Abstract

Since 2001, one intravenous proton pump inhibitor (pantoprazole) has been available in the United States. A drug shortage bulletin was issued for this agent in 2003. To evaluate the patterns of use of intravenous proton pump inhibitors (IV PPIs) in routine clinical practice. Prospective evaluation of IV PPI use in two community-based teaching hospitals. A computerized pharmacy ordering system was used to identify all patients for whom an IV PPI was ordered. Trained investigators obtained clinical data from patient records and these data were mapped to establish clinical criteria for the use of IV PPIs. Intravenous PPIs were prescribed in 238 patients over a 30-day period and a total of 1,631 doses were prescribed. Primary care providers prescribed 46% of prescriptions. Fifty-six percent of patients who received IV PPIs had no acceptable indication for their use. Of the 126 (81%) patients who were started on PPIs for the first time during their hospital stay, 102 were discharged on a PPI. Intravenous PPIs are widely used for poor indications, which may contribute to the shortage of these agents.

References

Jan 16, 2003·The American Journal of Gastroenterology·Brennan M R SpiegelNimish B Vakil

❮ Previous
Next ❯

Citations

Mar 21, 2009·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Wolfgang SchillingerGerd Hasenfuss
Feb 25, 2010·World Journal of Gastroenterology : WJG·Soumana C NasserHani I Dimassi
May 17, 2006·Alimentary Pharmacology & Therapeutics·P O KatzA N Barkun
Sep 11, 2007·Journal of Evaluation in Clinical Practice·Kevin O HwangRebecca A Griffith
Dec 25, 2010·Therapeutic Advances in Gastroenterology·Sandy H Pang, David Y Graham
Dec 7, 2017·Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates·Seyed Masoom MasoompourHamideh Mahdaviazad
May 10, 2007·European Journal of Gastroenterology & Hepatology·Eoin SlatteryHugh E Mulcahy
Aug 22, 2007·Surgical Endoscopy·David A EdelmanLisa G Hall Zimmerman
Nov 27, 2008·Digestive Diseases and Sciences·Jacob G HooverKevin J Franklin
Feb 19, 2008·Journal of Clinical Gastroenterology·Giorgio TalaminiItalo Vantini
Feb 20, 2007·Alimentary Pharmacology & Therapeutics·W AfifA N Barkun
Apr 1, 2011·Clinical Journal of Gastroenterology·T P Rakesh
Dec 4, 2015·Southern Medical Journal·Roberta E RedfernJennifer L Middleton
May 16, 2009·Drug Discovery Today·James M MullinJames J Thornton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.